RXRX Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
| Unit: USD | 2023-03-31 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|
| cash flows from operating activities | ||||||
| net income | -65,327,000 | -65,560,000 | -55,979,000 | -47,428,000 | -43,401,000 | -30,717,000 |
| adjustments to reconcile net income to net cash from operating activities: | ||||||
| depreciation and amortization | 3,728,000 | 2,786,000 | 2,767,000 | 2,436,000 | 2,331,000 | 1,402,000 |
| stock-based compensation | 8,814,000 | 5,675,000 | 5,632,000 | 3,363,000 | 5,317,000 | 1,821,000 |
| fixed asset impairment | 1,169,000 | |||||
| lease expense | 1,988,000 | 2,015,000 | 1,742,000 | |||
| other | 716,000 | 192,000 | 402,000 | 464,000 | 2,375,000 | 101,000 |
| changes in operating assets and liabilities: | ||||||
| other receivables and assets | -317,000 | -1,800,000 | -7,551,000 | |||
| unearned revenue | -12,134,000 | -7,653,000 | 144,701,000 | -2,500,000 | -2,500,000 | -2,500,000 |
| accounts payable | -339,000 | -986,000 | 1,344,000 | 3,130,000 | 71,000 | 2,051,000 |
| accrued development expense | 676,000 | 1,464,000 | 1,413,000 | 918,000 | 1,822,000 | -1,216,000 |
| accrued expenses and other current liabilities | -9,846,000 | |||||
| operating lease liabilities | -2,444,000 | -1,547,000 | -1,265,000 | |||
| net cash from operating activities | -73,316,000 | -61,623,000 | 77,388,000 | -33,048,000 | -33,653,000 | -30,755,000 |
| cash flows from investing activities | ||||||
| purchases of property and equipment | -5,175,000 | -16,475,000 | -4,342,000 | -9,706,000 | -6,212,000 | -19,416,000 |
| purchase of an intangible asset | -165,000 | |||||
| sales and maturities of investments | 21,415,000 | 147,646,000 | ||||
| net cash from investing activities | -5,340,000 | 4,940,000 | 143,304,000 | -193,873,000 | -6,212,000 | -19,416,000 |
| cash flows from financing activities | ||||||
| proceeds from equity incentive plans | 1,946,000 | 2,690,000 | 2,106,000 | |||
| repayment of long-term debt | -24,000 | -22,000 | -22,000 | -12,737,000 | -20,000 | -20,000 |
| net cash from financing activities | 1,922,000 | 2,668,000 | 2,084,000 | -11,095,000 | 463,705,000 | 2,134,000 |
| effect of exchange rate changes on cash, cash equivalents and restricted cash | -2,000 | |||||
| net change in cash, cash equivalents and restricted cash | -76,736,000 | -54,015,000 | 222,776,000 | -238,016,000 | 423,840,000 | -48,037,000 |
| cash, cash equivalents and restricted cash, beginning of period | 559,112,000 | 0 | 295,349,000 | 0 | 0 | 267,167,000 |
| cash, cash equivalents and restricted cash, end of period | 482,376,000 | -54,015,000 | 518,125,000 | -238,016,000 | 423,840,000 | 219,130,000 |
| supplemental schedule of non-cash investing and financing activities | ||||||
| accrued property and equipment | 244,000 | -154,000 | 4,328,000 | -350,000 | 58,000 | 705,000 |
| right-of-use asset additions and modifications | 3,520,000 | |||||
| financed equipment purchase | 1,214,000 | |||||
| supplemental schedule of cash flow information | ||||||
| cash paid for operating leases | 2,444,000 | 1,547,000 | 1,265,000 | |||
| cash paid for interest | 13,000 | 14,000 | 14,000 | 125,000 | 286,000 | 254,000 |
| accrued expenses, deferred rent and other current liabilities | 1,070,000 | -15,903,000 | 10,126,000 | -136,000 | 1,133,000 | |
| proceeds from initial public offering of common stock, net of issuance costs | 0 | |||||
| conversion of preferred stock to common stock | 0 | |||||
| deferred issuance costs recorded in equity | 0 | |||||
| right-of-use asset additions | 1,548,000 | |||||
| asset impairment | ||||||
| loss on debt extinguishment | ||||||
| accounts receivable | 16,000 | 13,000 | 85,000 | |||
| acquisition of a business | ||||||
| purchases of investments | ||||||
| proceeds from note receivable | ||||||
| proceeds from sale of preferred stock, net of issuance costs | ||||||
| proceeds from convertible notes | ||||||
| supplemental disclosure of non—cash investing and financing information | ||||||
| conversion of convertible notes to equity | ||||||
| supplemental disclosure of cash flow information | ||||||
| other assets | 455,000 | -2,915,000 | ||||
| proceeds from exercise of stock options | 824,000 | 2,154,000 | ||||
| deferred issuance costs | 2,997,000 |